-
Mercati
-
Azioni
Sustainable finance2025 Euronext ESG Trends ReportLeggi tuttoA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indici
Access the white paperInvesting in the future of Europe with innovative indicesLeggi tuttoThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLeggi tuttoInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fondi
-
Obbligazioni
European Defence BondsGroupe BPCE lists the first bondLeggi tuttoFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Prodotti strutturati
-
Derivati
Where European Government Bonds Meet the FutureFixed Income derivativesLeggi tuttoTrade mini bond futures on main European government bonds
-
Commodities
- Panoramica
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Consegna e liquidazione
- Specifiche e disposizioni
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLeggi tuttoEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Documenti e risorse
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLeggi tuttoJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Crossject
Identification
Nome strumento
CROSSJECT
Ticker
ALCJ
Codice ISIN
FR0011716265
Mercato
Euronext Growth
Borsa
Paris
Products family
Stocks
ICB
Medical Supplies
Activity description
Crossject est spécialisé dans la fabrication et la commercialisation de systèmes d’auto-injection médicamenteuse sans aiguille. Le groupe propose Zeneo, un dispositif pré-rempli et à usage unique, pouvant être utilisé pour des injections intradermiques, sous cutanées et intramusculaires. Le CA par activité se répartit comme suit :
- prestations de collaboration sur le méthotrexate (70,6%) ;
- prestations de collaboration sur le traitement des oedèmes maculaires (28,3%) ;
- autres (1,1%).
La totalité du CA est réalisée en France.
Indirizzo web
http://www.crossject.com/
Operation
Data IPO
Gio 20/02/2014
Tipologia IPO
Introduction par offre au public
Prezzo IPO
8,38 EUR
Tipologia IPO
Initial Public offering
Categoria
IPO
Intervallo di prezzo
EUR 7.21 - EUR 8.38
Capitale raccolto
17